Global Cancer/Tumor Profiling Market Size, Trends & Analysis - Forecasts to 2026

Global Cancer/Tumor Profiling Market Size, Trends & Analysis - Forecasts to 2026

By Cancer Type (Breast Cancer, Colorectal Cancer, Prostate Cancer, Lung Cancer, Melanoma, Others), By Biomarker Type (Genomic Biomarker, Protein Biomarker), By Application (Clinical Application, Research Application), By Technology (Immunoassays, Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays, Mass Spectrometry, Others), By Region (North America, Europe, Asia Pacific, MEA, CSA); Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis

Cancer/Tumor Profiling Market: Insights

The global cancer/tumor profiling market is estimated to witness a significant CAGR during the forecast period (2020-2026). The increase in demand for personalized medicine along with rising use of biomarkers in cancer profiling are some of the major factors driving the market growth.

 

Request a free sample copy of the report @https://www.globalmarketestimates.com/market-report/global-cancer-tumor-profiling-market-2171

 

Cancer/Tumor Profiling Market: By Cancer Type

On the basis of cancer type, the global cancer/tumor profiling market is segmented into breast cancer, colorectal cancer, prostate cancer, melanoma, and lung cancer, among others.  The report contains quantitative insights about the following:

1.1.  Introduction 

1.1.1.     Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)     

1.2.  Breast Cancer          

1.2.1.     Breast Cancer: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)       

1.3.  Colorectal Cancer    

1.3.1.     Colorectal Cancer: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

1.4.  Prostate Cancer       

1.4.1.     Prostate Cancer: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

1.5.  Lung Cancer 

1.5.1.     Lung Cancer: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

1.6.  Melanoma   

1.6.1.     Melanoma: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

1.7.  Others           

1.7.1.     Others: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

Cancer/Tumor Profiling Market: By Application

On the basis of application, the global cancer/tumor profiling market is segmented into clinical application, and research application.  The report contains quantitative insights about the following:

1.1.  Introduction 

1.1.1.     Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)      

1.2.  Clinical Application 

1.2.1.     Clinical Application: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

1.2.1.1.          Diagnostics: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)           

1.2.1.2.          Screening: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)  

1.2.1.3.          Prognostics: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)           

1.2.1.4.          Monitoring & Treatment: Cancer/Tumor Profiling Market, 2020-2026 (USD Million) 

1.3.  Research Application         

1.3.1.     Research Application: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

1.3.1.1.          Personalized Medicines: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)  

1.3.1.2.          Biomarker Discovery: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)       

 

Cancer/Tumor Profiling Market: By Biomarker Type

On the basis of biomarker type, the global cancer/tumor profiling market is segmented into genomic biomarker, and protein biomarker, among others. The report contains quantitative insights about the following:

1.1.  Introduction 

1.1.1.     Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)

1.2.  Genomic Biomarker           

1.2.1.     Genomic Biomarker: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

1.3.  Protein Biomarker  

1.3.1.     Protein Biomarker: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

1.4.  Others           

1.4.1.     Others: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

Cancer/Tumor Profiling Market: By Technology

On the basis of technology, the global cancer/tumor profiling market is segmented into immunoassays, next generation sequencing, polymerase chain reaction, in situ hybridization, microarrays, and mass spectrometry, among others. The report contains quantitative insights about the following:

1.1.  Introduction 

1.1.1.     Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)      

1.2.  Immunoassays        

1.2.1.     Immunoassays: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

1.3.  Next Generation Sequencing         

1.3.1.     Next Generation Sequencing: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

1.4.  Polymerase Chain Reaction          

1.4.1.     Polymerase Chain Reaction: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

1.5.  In Situ Hybridization           

1.5.1.     In Situ Hybridization: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

1.6.  Microarrays  

1.6.1.     Microarrays: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

1.7.  Mass Spectrometry 

1.7.1.     Mass Spectrometry: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

1.8.  Others           

1.8.1.     Others: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

Cancer/Tumor Profiling Market: By Region

On the basis of region, the global cancer/tumor profiling market is segmented into North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. The countries covered include: U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Saudi Arabia, UAE, and South Africa among others. The report provides qualitative & quantitative insights both at a regional as well as country level.

1.1.  Introduction 

1.1.1.     Global Cancer/Tumor Profiling Market, Regional Analysis, 2020-2026 (USD Million)

1.2.  North America         

1.2.1.     North America Cancer/Tumor Profiling Market, Regional Analysis, 2020-2026 (USD Million)   

1.2.1.1.          By Cancer Type         

1.2.1.1.1.                North America Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)         

1.2.1.2.          By Application          

1.2.1.2.1.                North America Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)         

1.2.1.3.          By Biomarker Type   

1.2.1.3.1.                North America Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)           

1.2.1.4.          By Technology          

1.2.1.4.1.                North America Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)         

1.2.1.5.          By Country     

1.2.1.5.1.                U.S     

1.2.1.5.1.1.                     By Cancer Type         

1.2.1.5.1.1.1.   U.S Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)    

1.2.1.5.1.2.                     By Application          

1.2.1.5.1.2.1.   U.S Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)    

1.2.1.5.1.3.                     By Biomarker Type   

1.2.1.5.1.3.1.   U.S Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)    

1.2.1.5.1.4.                     By Technology          

1.2.1.5.1.4.1.   U.S Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)    

1.2.1.5.2.                Canada.         

1.2.1.5.2.1.                     By Cancer Type         

1.2.1.5.2.1.1.   Canada Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)    

1.2.1.5.2.2.                     By Application          

1.2.1.5.2.2.1.   Canada Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)    

1.2.1.5.2.3.                     By Biomarker Type   

1.2.1.5.2.3.1.   Canada Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)      

1.2.1.5.2.4.                     By Technology          

1.2.1.5.2.4.1.   Canada Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)    

1.2.1.5.3.                Mexico           

1.2.1.5.3.1.                     By Cancer Type         

1.2.1.5.3.1.1.   Mexico Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)    

1.2.1.5.3.2.                     By Application          

1.2.1.5.3.2.1.   Mexico Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)    

1.2.1.5.3.3.                     By Biomarker Type   

1.2.1.5.3.3.1.   Mexico Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)                  

1.2.1.5.3.4.                     By Technology          

1.2.1.5.3.4.1.   Mexico Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)

1.3.  Europe          

1.3.1.     Europe Cancer/Tumor Profiling Market, Regional Analysis, 2020-2026 (USD Million)           

1.3.1.1.          By Cancer Type         

1.3.1.1.1.                Europe Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)         

1.3.1.2.          By Application          

1.3.1.2.1.                Europe Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)          

1.3.1.3.          By Biomarker Type   

1.3.1.3.1.                Europe Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)         

1.3.1.4.          By Technology          

1.3.1.4.1.                Europe Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)

1.3.1.5.          By Country     

1.3.1.5.1.                Germany        

1.3.1.5.1.1.                     By Cancer Type         

1.3.1.5.1.1.1.   Germany Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)      

1.3.1.5.1.2.                     By Application          

1.3.1.5.1.2.1.   Germany Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)      

1.3.1.5.1.3.                     By Biomarker Type   

1.3.1.5.1.3.1.   Germany Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)                  

1.3.1.5.1.4.                     By Technology          

1.3.1.5.1.4.1.   Germany Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)

1.3.1.5.2.                UK      

1.3.1.5.2.1.                     By Cancer Type         

1.3.1.5.2.1.1.   UK Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)    

1.3.1.5.2.2.                     By Application          

1.3.1.5.2.2.1.   UK Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)    

1.3.1.5.2.3.                     By Biomarker Type   

1.3.1.5.2.3.1.   UK Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)    

1.3.1.5.2.4.                     By Technology          

1.3.1.5.2.4.1.   UK Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)    

1.3.1.5.3.                France

1.3.1.5.3.1.                     By Cancer Type         

1.3.1.5.3.1.1.   France Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)    

1.3.1.5.3.2.                     By Application          

1.3.1.5.3.2.1.   France Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)    

1.3.1.5.3.3.                     By Biomarker Type   

1.3.1.5.3.3.1.   France Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)                  

1.3.1.5.3.4.                     By Technology          

1.3.1.5.3.4.1.   France Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)

 

1.3.1.5.4.                Italy    

1.3.1.5.4.1.                     By Cancer Type         

1.3.1.5.4.1.1.   Italy Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)    

1.3.1.5.4.2.                     By Application          

1.3.1.5.4.2.1.   Italy Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)    

1.3.1.5.4.3.                     By Biomarker Type   

1.3.1.5.4.3.1.   Italy Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)      

1.3.1.5.4.4.                     By Technology          

1.3.1.5.4.4.1.   Italy Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)    

1.3.1.5.5.                Rest Of Europe          

1.3.1.5.5.1.                     By Cancer Type         

1.3.1.5.5.1.1.   Rest Of Europe Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)        

1.3.1.5.5.2.                     By Application          

1.3.1.5.5.2.1.   Rest Of Europe Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)        

1.3.1.5.5.3.                     By Biomarker Type   

1.3.1.5.5.3.1.   Rest Of Europe Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)                    

1.3.1.5.5.4.                     By Technology          

1.3.1.5.5.4.1.   Rest Of Europe Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)

 

1.4.  Asia Pacific  

1.4.1.     Asia Pacific Cancer/Tumor Profiling Market, Regional Analysis, 2020-2026 (USD Million)   

1.4.1.1.          By Cancer Type         

1.4.1.1.1.                Asia Pacific Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)         

1.4.1.2.          By Application          

1.4.1.2.1.                Asia Pacific Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)         

1.4.1.3.          By Biomarker Type   

1.4.1.3.1.                Asia Pacific Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)

1.4.1.4.          By Technology          

1.4.1.4.1.                Asia Pacific Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)                     

1.4.1.5.          By Country     

1.4.1.5.1.                China 

1.4.1.5.1.1.                     By Cancer Type         

1.4.1.5.1.1.1.   China Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)    

1.4.1.5.1.2.                     By Application          

1.4.1.5.1.2.1.   China Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)    

1.4.1.5.1.3.                     By Biomarker Type   

1.4.1.5.1.3.1.   China Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)                  

1.4.1.5.1.4.                     By Technology          

1.4.1.5.1.4.1.   China Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)

1.4.1.5.2.                Japan 

1.4.1.5.2.1.                     By Cancer Type         

1.4.1.5.2.1.1.   Japan Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)    

1.4.1.5.2.2.                     By Application          

1.4.1.5.2.2.1.   Japan Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)    

1.4.1.5.2.3.                     By Biomarker Type   

1.4.1.5.2.3.1.   Japan Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)      

1.4.1.5.2.4.                     By Technology

1.4.1.5.2.4.1.   Japan Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)

1.4.1.5.3.                India  

1.4.1.5.3.1.                     By Cancer Type         

1.4.1.5.3.1.1.   India Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)    

1.4.1.5.3.2.                     By Application          

1.4.1.5.3.2.1.   India Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)    

1.4.1.5.3.3.                     By Biomarker Type   

1.4.1.5.3.3.1.   India Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)      

1.4.1.5.3.4.                     By Technology          

1.4.1.5.3.4.1.   India Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)    

1.4.1.5.4.                South Korea  

1.4.1.5.4.1.                     By Cancer Type         

1.4.1.5.4.1.1.   South Korea Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)      

1.4.1.5.4.2.                     By Application          

1.4.1.5.4.2.1.   South Korea Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)      

1.4.1.5.4.3.                     By Biomarker Type   

1.4.1.5.4.3.1.   South Korea Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)                    

1.4.1.5.4.4.                     By Technology          

1.4.1.5.4.4.1.   South Korea Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)

1.5.  Central & South America   

1.5.1.     Central & South America Cancer/Tumor Profiling Market, Regional Analysis, 2020-2026 (USD Million)  

1.5.1.1.          By Cancer Type         

1.5.1.1.1.                Central & South America Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million) 

1.5.1.2.          By Application          

1.5.1.2.1.                Central & South America Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million) 

1.5.1.3.          By Biomarker Type   

1.5.1.3.1.                Central & South America Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)   

1.5.1.4.          By Technology          

1.5.1.4.1.                Central & South America Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)

1.5.1.5.          By Country     

1.5.1.5.1.                Brazil 

1.5.1.5.1.1.                     By Cancer Type         

1.5.1.5.1.1.1.   Brazil Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)    

1.5.1.5.1.2.                     By Application          

1.5.1.5.1.2.1.   Brazil Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)    

1.5.1.5.1.3.                     By Biomarker Type   

1.5.1.5.1.3.1.   Brazil Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)                  

1.5.1.5.1.4.                     By Technology          

1.5.1.5.1.4.1.   Brazil Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)

1.6.  Middle East & Africa           

1.6.1.     Middle East & Africa Cancer/Tumor Profiling Market, Regional Analysis, 2020-2026 (USD Million)  

1.6.1.1.          By Cancer Type         

1.6.1.1.1.                Middle East & Africa Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)           

1.6.1.2.          By Application          

1.6.1.2.1.                Middle East & Africa Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)           

1.6.1.3.          By Biomarker Type   

1.6.1.3.1.                Middle East & Africa Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million) 

1.6.1.4.          By Technology          

1.6.1.4.1.                Middle East & Africa Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)           

1.6.1.5.          By Country     

1.6.1.5.1.                Saudi Arabia 

1.6.1.5.1.1.                     By Cancer Type         

1.6.1.5.1.1.1.   Saudi Arabia Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)      

1.6.1.5.1.2.                     By Application          

1.6.1.5.1.2.1.   Saudi Arabia Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)      

1.6.1.5.1.3.                     By Biomarker Type   

1.6.1.5.1.3.1.   Saudi Arabia Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)                    

1.6.1.5.1.4.                     By Technology          

1.6.1.5.1.4.1.   Saudi Arabia Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)

1.6.1.5.2.                UAE    

1.6.1.5.2.1.                     By Cancer Type         

1.6.1.5.2.1.1.   UAE Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)    

1.6.1.5.2.2.                     By Application          

1.6.1.5.2.2.1.   UAE Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)    

1.6.1.5.2.3.                     By Biomarker Type   

1.6.1.5.2.3.1.   UAE Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)      

1.6.1.5.2.4.                     By Technology          

1.6.1.5.2.4.1.   UAE Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)

Cancer/Tumor Profiling Market: Share & Competitor Analysis

Some of the key players operating in the cancer/tumor profiling market include: ILLUMINA, Inc., Qiagen N.V., Neogenomics, Inc., Sysmex Corporation, HTG Molecular Diagnostics, Inc., Helomics Corporation, Caris Life Sciences, Nanostring Technologies, Inc., Ribomed Biotechnologies, Inc., Guardant Health, Inc., Foundation Medicine, F. Hoffmann-La Roche Ltd., Genscript Biotech Corporation, Tempus Labs, Histogene X, Hologic, Inc., Boreal Genomics Inc., Perthera, Agendia, and Omniseq, among others.

Browse the report @https://www.globalmarketestimates.com/market-report/global-cancer-tumor-profiling-market-2171